Youfeng Yang

5.2k total citations · 1 hit paper
64 papers, 3.8k citations indexed

About

Youfeng Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Youfeng Yang has authored 64 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Youfeng Yang's work include Renal cell carcinoma treatment (26 papers), Renal and related cancers (22 papers) and Cancer Genomics and Diagnostics (9 papers). Youfeng Yang is often cited by papers focused on Renal cell carcinoma treatment (26 papers), Renal and related cancers (22 papers) and Cancer Genomics and Diagnostics (9 papers). Youfeng Yang collaborates with scholars based in United States, China and Japan. Youfeng Yang's co-authors include W. Marston Linehan, Tzuling Cheng, Navdeep S. Chandel, Ralph J. DeBerardinis, William W. Wheaton, Lucas B. Sullivan, Andrew R. Mullen, Eunsook S. Jin, Pei-Hsuan Chen and Maria J. Merino and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Youfeng Yang

63 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reductive carboxylation supports growth in tumour cells with defective mitochondria

2011 1.0k citations Andrew R. Mullen, William W. Wheaton et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Youfeng Yang United States	30	2.7k	1.6k	1.2k	335	318	64	3.8k
Shahriar Koochekpour United States	34	2.2k 0.8×	979 0.6×	912 0.8×	144 0.4×	723 2.3×	84	3.8k
Chunru Lin United States	27	4.3k 1.6×	2.8k 1.7×	656 0.5×	133 0.4×	505 1.6×	47	5.3k
Gary G. Chiang United States	23	2.9k 1.1×	900 0.6×	402 0.3×	240 0.7×	666 2.1×	47	3.8k
Zachary E. Stine United States	16	3.1k 1.2×	2.5k 1.6×	387 0.3×	311 0.9×	791 2.5×	23	4.6k
Zandra E. Walton United States	15	2.2k 0.8×	1.2k 0.7×	416 0.3×	290 0.9×	942 3.0×	23	3.5k
Chunzhang Yang United States	39	1.9k 0.7×	1.9k 1.2×	336 0.3×	368 1.1×	492 1.5×	102	4.2k
Gerta Hoxhaj United States	18	2.7k 1.0×	878 0.5×	258 0.2×	408 1.2×	456 1.4×	24	3.7k
Ben Tycko United States	5	3.3k 1.2×	792 0.5×	517 0.4×	387 1.2×	834 2.6×	6	4.3k
Santiago Ropero Spain	35	4.8k 1.8×	2.5k 1.5×	386 0.3×	221 0.7×	750 2.4×	65	6.0k
Roger Abounader United States	43	3.9k 1.5×	2.6k 1.6×	443 0.4×	118 0.4×	951 3.0×	86	5.8k

Countries citing papers authored by Youfeng Yang

Since Specialization

Citations

This map shows the geographic impact of Youfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youfeng Yang more than expected).

Fields of papers citing papers by Youfeng Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youfeng Yang. The network helps show where Youfeng Yang may publish in the future.

Co-authorship network of co-authors of Youfeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Youfeng Yang. A scholar is included among the top collaborators of Youfeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youfeng Yang. Youfeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukushima, Hiroshi, Aki Furusawa, Youfeng Yang, et al.. (2025). Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma. International Journal of Cancer. 156(12). 2377–2388. 1 indexed citations

Nicola, Teodora, Xin Xu, Gabriel Rezonzew, et al.. (2024). A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation. Nature Communications. 15(1). 7113–7113. 12 indexed citations

Baptista, Liliana C., Zachary Graham, Abbi R. Hernandez, et al.. (2023). Multiomics profiling of the impact of an angiotensin (1–7)-expressing probiotic combined with exercise training in aged male rats. Journal of Applied Physiology. 134(5). 1135–1153. 2 indexed citations

Yang, Youfeng, et al.. (2021). Interactive Effects of Enalapril Administration and Novel HIIT Wheel-Bed Training in Aged Rats. SHILAP Revista de lepidopterología. 2.

Liu, Xin, Tianshu Wang, Youfeng Yang, et al.. (2020). ScPNP-A, a plant natriuretic peptide from Stellera chamaejasme, confers multiple stress tolerances in Arabidopsis. Plant Physiology and Biochemistry. 149. 132–143. 5 indexed citations

Bak, Daniel W., Daniel R. Crooks, Youfeng Yang, et al.. (2020). Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite. Journal of Biological Chemistry. 295(39). 13410–13418. 5 indexed citations

Xing, Hong, Yi Sheng, Mark P. DeAndrade, et al.. (2020). BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome. Brain Structure and Function. 225(6). 1743–1760. 19 indexed citations

Kauffman, Eric, Martin Lang, Soroush Rais‐Bahrami, et al.. (2019). Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion. BMC Cancer. 19(1). 917–917. 15 indexed citations

Saxena, Neetu, Nunziata Maio, Daniel R. Crooks, et al.. (2015). SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery. JNCI Journal of the National Cancer Institute. 108(1). djv287–djv287. 97 indexed citations

10.

Sourbier, Carole, Christopher J. Ricketts, Shingo Matsumoto, et al.. (2014). Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer. Cancer Cell. 26(6). 840–850. 84 indexed citations

11.

Yang, Youfeng, Andrew N. Lane, Christopher J. Ricketts, et al.. (2013). Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma. PLoS ONE. 8(8). e72179–e72179. 85 indexed citations

12.

Ding, Qiang, Meng Hu, Youfeng Yang, et al.. (2013). FAK-Related Nonkinase Is a Multifunctional Negative Regulator of Pulmonary Fibrosis. American Journal Of Pathology. 182(5). 1572–1584. 46 indexed citations

13.

Sourbier, Carole, Manik C. Ghosh, Youfeng Yang, et al.. (2012). Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma. Oncotarget. 3(11). 1472–1482. 19 indexed citations

14.

Zhong, Minghao, Lisa C. Osborne, Alberto Paniz‐Mondolfi, et al.. (2012). Translocation Renal Cell Carcinomas in Adults. The American Journal of Surgical Pathology. 36(5). 654–662. 77 indexed citations

15.

Mullen, Andrew R., William W. Wheaton, Eunsook S. Jin, et al.. (2011). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 481(7381). 385–388. 1004 indexed citations breakdown →

16.

Ford, Jill, O. M. Zack Howard, Jeff Subleski, et al.. (2010). Enhanced Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) and Soluble TREM-1 Levels in the Myeloid Cells of Tumor-Bearing Mice and Patients with Renal Cell Carcinoma (100.8). The Journal of Immunology. 184(Supplement_1). 100.8–100.8. 1 indexed citations

17.

Sourbier, Carole, Alessio Giubellino, Youfeng Yang, et al.. (2010). Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma. Cell Cycle. 9(20). 4183–4189. 25 indexed citations

18.

Yang, Youfeng, Vladimir Valera, Hesed Padilla‐Nash, et al.. (2009). UOK 262 cell line, fumarate hydratase deficient (FH−/FH−) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genetics and Cytogenetics. 196(1). 45–55. 112 indexed citations

19.

Tsuda, Hiroshi, Sung Min Han, Youfeng Yang, et al.. (2008). The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors. Cell. 133(6). 963–977. 176 indexed citations

20.

Vocke, Cathy D., Youfeng Yang, Christian P. Pavlovich, et al.. (2005). High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dubé–Associated Renal Tumors. JNCI Journal of the National Cancer Institute. 97(12). 931–935. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact